What is afami-cel?: A Guide to the First T-Cell Therapy for a Solid Tumor
•
4 min read
In August 2024, the FDA granted accelerated approval to afamitresgene autoleucel (afami-cel), making it the first T-cell receptor (TCR) therapy approved for a solid tumor [1.4.2]. So, **what is afami-cel** and how does this innovative treatment work for patients with advanced synovial sarcoma?
